Story perspectives

Ontario Launches RSV Vaccine Program for High-Risk Seniors

9/12/2025

48 10

Summary

Story summary

Ontario will fund the high-risk older adult RSV vaccine program for the 2025-2026 season, utilizing Arexvy and Abrysvo™.
Eligible individuals include those aged 75+, long-term care residents, and individuals with certain health conditions.
Previous RSV vaccine recipients do not require another dose this season.
Hospitals can order RSV vaccines starting September 8, 2025; healthcare providers can order from September 15, 2025.
The infant RSV prevention program will use Beyfortus® for infants and high-risk children, and Abrysvo™ for pregnant individuals.

1 of 1

Story summary

Ontario will fund the high-risk older adult RSV vaccine program for the 2025-2026 season, utilizing Arexvy and Abrysvo™.
Eligible individuals include those aged 75+, long-term care residents, and individuals with certain health conditions.
Previous RSV vaccine recipients do not require another dose this season.
Hospitals can order RSV vaccines starting September 8, 2025; healthcare providers can order from September 15, 2025.
The infant RSV prevention program will use Beyfortus® for infants and high-risk children, and Abrysvo™ for pregnant individuals.